CROs Are Back, Many with Specialties

by | Nov 18, 2016 4:12 pm | Other Services, Private Equity | 0 comments

We’ve documented the increase in biotechnology acquisitions and license deals by pharmaceutical companies in previous posts. But the impact of pharma’s move away from in-house R&D has benefited other sectors of the healthcare industry, particularly clinical research organizations (CROs). For those outside the technology side of healthcare, CROs provide outsourced research services to the pharmaceutical, biotechnology, and medical device industries on a contract basis. Through mid-November, we’ve seen an increase of 325% in deal volume for CROs, compared with the year before. In 2015, just five deals for these targets were announced. So far this year, 17 are on the... Read More »

November Sees a Surge in Lab Deals

by | Nov 17, 2016 8:00 am | Laboratories, MRI & Dialysis, Private Equity | 0 comments

Four deals in our Laboratories, MRI & Dialysis sector have been announced in the first half of November. That much activity constitutes a surge for this sector, which now stands at 39 deals through all of 2016. With only six weeks left in the year, it seems unlikely that this sector will surpass 2015’s total of 52 deals. On November 1st, Vital Images, Inc., a subsidiary of Toshiba Medical Systems Group, acquired Karos Health for an undisclosed price. Karos Health provides standards-based clinical imaging exchange and cross-enterprise workflow and diagnostic imaging solutions. The combined technologies provide a customer-centric, modular platform that allows hospital systems to solve a... Read More »

What U.S. Hospitals Are Acquiring in 2016

by | Nov 16, 2016 8:45 pm | Behavioral Health Care, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Other Services, Physician Medical Groups | 0 comments

Hospital acquisitions have surged since the Affordable Care Act was passed in 2010. That year, 76 deals were announced, with a U.S. hospital or health system as a target. By 2012, 107 transactions were recorded for hospital targets, and that still stands as the highest number of deals per year. Only 2015 came close, with 102 hospital transactions. Through mid-November, there have been 79 deals announced with U.S. hospitals or health systems as the target. But what are U.S. hospitals acquiring for their own financial health? Other hospitals or health systems make up the majority of targets every year, of course.  So far this year, through mid November, 66 transactions... Read More »

Boston Scientific Seeks Out Portfolio Acquisitions

by | Nov 15, 2016 4:57 pm | Medical Devices | 0 comments

Earlier this year, Boston Scientific Corporation (NYSE: BSX) acquired two companies: Cosman Medical Inc. to strengthen its neuromodulation business and EndoChoice Holdings Inc. to strengthen its pathology services and imaging technologies. Since then, the medical device giant has toned down its acquiring habits with two asset/portfolio purchases in November. On November 3, 2016, the company acquired the LumenR™ Tissue Retractor System from LumenR LLC. It is currently in development for use during endoscopic resection of lesions in the colon, esophagus or stomach. Boston Scientific will conduct additional development and evaluation of the system prior to commercialization. On November 15,... Read More »